Bristol Myers Squibb to Participate in Raymond James Virtual 42nd Annual Institutional Investors Conference
Bristol Myers Squibb (NYSE: BMY) will participate in a fireside chat at the Raymond James Virtual 42nd Annual Institutional Investors Conference on March 2, 2021, at 8:20 a.m. ET. David Elkins, CFO, will discuss the company's strategies and answer investor questions. The session will be broadcast live, and the public can access it via http://investor.bms.com. An archived version will also be available later that day. Bristol Myers Squibb is committed to delivering innovative medicines for serious diseases.
- None.
- None.
Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Raymond James’ Virtual 42nd Annual Institutional Investors Conference, which will be webcast on Tuesday, March 2, 2021. David Elkins, Executive Vice President, Chief Financial Officer will answer questions about the company at 8:20 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210223005058/en/
FAQ
When will Bristol Myers Squibb participate in the Raymond James conference?
Who will represent Bristol Myers Squibb at the conference?
What time is the Bristol Myers Squibb presentation at the conference?
How can the public access the Bristol Myers Squibb conference session?